A study found no significant differences in the risk for PsA among patients with psoriasis treated with interleukin (IL)-23 ...

This new study confirms the noninferiority of extended dosing intervals for psoriasis control in super responders.

Our skin–the body's largest organ–provides the first line of defense against infections and many other threats to our health.

Inflammatory markers can indicate treatment efficacy and predict super-responder status in patients with psoriasis treated ...

Back-to-back failures in psoriasis and Crohn’s disease have forced Ventyx Biosciences to abandon the development of its ...

More than 90% of patients had a psoriasis area and severity index (PASI) score <3 at 68 weeks regardless of whether they received the interleukin (IL)-23 inhibitor every 8 or 16 weeks. Clinical signs ...

Pustular psoriasis is a skin disease. You'll see white bumps filled with pus near or inside red skin blotches. These are called pustules. They can hurt and be scaly, flaky, or itchy. Note the ...

Psoriasis is an autoimmune condition that affects the skin. Most people with psoriasis have plaque psoriasis, but there are several other types as well. Psoriasis is a skin condition that can ...

No matter the task, we're tracking every last dollar from start to finish. Up next: treating scalp psoriasis. It was only after she visited a dermatologist for treatment that she started to see ...

In rat inflammation models, tissue-specific signs of inflammation and IL-23-induced signaling were lower in ... 2 clinical trials of JNJ-2113 in plaque psoriasis. JNJ-2113 continues to distinguish ...

Psoriasis causes inflammation and a quicker turnover of skin cells, leaving itchy, red patches of skin. You can try changing your diet to help relieve some symptoms. When too many cells rise to ...

At least half of people with psoriasis have it on their scalp. The skin cells on your scalp grow too quickly and make powdery or thick scales called plaques. The areas around them can be red and ...